Tender detail
Non-exclusive rebate agreement for medicinal products containing clonazepam
Summary
The tender concerns the conclusion of a non-exclusive rebate agreement for medicinal products containing the active substance clonazepam for the period 01/08/2026 to 31/07/2028, with an option to extend the contract once by 12 months. DAK-Gesundheit intends to conclude agreements with as many interested pharmaceutical companies as possible for the medicinal products to be specified by the bidder in Annex 2 to the contract.
More tender information after sign-in
The public view shows key tender details. Sign in to open official links, documents and AI tender support.